Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PaperCitations, authors & open-access status

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 116 citations, 2023 year and hybrid oa status.

116
Citations
2023
Year
hybrid
OA Status

Related on ScholarIQ

Dominik Steubl
Author
Takaya Sasaki
Author
Amy K. Mottl
Author
Giovanna Leoncini
Author
Kieran McCafferty
Author
Ying Yao
Author
470M+ articles · free account